| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 84.39B | 80.92B | 64.51B | 51.09B | 46.77B | 48.69B |
| Gross Profit | 11.70B | 10.11B | 8.64B | 7.26B | 6.04B | 6.62B |
| EBITDA | 9.04B | 9.07B | 6.60B | 6.39B | 4.98B | 4.78B |
| Net Income | 3.99B | 3.09B | 2.49B | 2.15B | 1.83B | 2.04B |
Balance Sheet | ||||||
| Total Assets | 167.64B | 167.04B | 155.91B | 126.19B | 123.42B | 123.28B |
| Cash, Cash Equivalents and Short-Term Investments | 6.06B | 4.98B | 6.35B | 8.42B | 7.46B | 16.53B |
| Total Debt | 76.75B | 77.16B | 70.56B | 54.36B | 56.52B | 59.34B |
| Total Liabilities | 108.33B | 108.66B | 99.85B | 78.31B | 77.86B | 80.35B |
| Stockholders Equity | 59.31B | 58.38B | 51.81B | 44.61B | 42.61B | 40.26B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -4.90B | -8.70B | 5.06B | -5.75B | -2.72B |
| Operating Cash Flow | 0.00 | 5.80B | 3.68B | 6.98B | 4.24B | 4.04B |
| Investing Cash Flow | 0.00 | -10.03B | -16.97B | -3.05B | -9.72B | -6.33B |
| Financing Cash Flow | 0.00 | 2.86B | 11.22B | -2.97B | -3.58B | 8.92B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥11.03B | 5.41 | ― | 4.99% | 6.11% | 207.55% | |
71 Outperform | ¥24.02B | 3.25 | ― | 1.29% | 4.21% | 35.32% | |
70 Outperform | ¥18.54B | 15.36 | ― | 1.38% | 7.07% | 26.88% | |
65 Neutral | ¥13.15B | 1,812.20 | ― | 5.77% | 3.22% | -87.75% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥47.70B | 12.05 | ― | 2.84% | 14.25% | 124.92% | |
50 Neutral | ¥6.56B | 19.26 | ― | 0.30% | -0.38% | 413.00% |